COMBINATION THERAPY OF AN ANTI CD20 ANTIBODY WITH A BTK INHIBITOR

Abstract: the present invention is directed to the combination therapy of an anti-cd20 antibody with a btk inhibitor for the treatment of cancer, especially to the combination therapy of cd20 expressing cancers with a type i anti-cd20 antibody or an afuocosylated humanized b-ly1 antibody and a btk inhibitor.

Inventor(s): Christian Klein, Toshio Yoshizawa, Tomoko Yasuhiro

CPC Classification: A61K39/39558 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))

Search for rejections for patent application number 20250205333